top-flor: treatment of newly-diagnosed fl with golcadomide, rituximab /- nivolumab
Published 8 months ago • 155 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
2:19
1st flor: nivolumab and rituximab in follicular lymphoma
-
3:52
results of relevance: frontline rituximab-lenalidomide for follicular lymphoma
-
1:25
targeted therapy for the treatment of follicular lymphoma
-
0:44
the recent fda approval of ponatinib for ph all following success in the phallcon trial
-
1:28
a long-term analysis of lenalidomide and rituximab for the treatment of cll
-
1:11
exciting updates in all and the value of novel immunotherapies
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
1:30
evaluating the optimal duration of cpx-351 treatment & best timing for allosct consolidation in aml
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
1:35
pirtobrutinib in r/r fl: results from the bruin study
-
2:13
rituximab ± lenalidomide as maintenance therapy in elderly patients with r/r fl
-
0:52
a real-world study of the optimal duration of cpx-351 treatment in patients with aml
-
1:33
sabrina trial: subcutaneous versus intravenous rituximab for follicular lymphoma
-
2:10
ilyad study: vitamin d supplementation in low tumor-burden indolent nhl treated with rituximab
-
2:43
interim analysis of the elm-2 study: odronextamab in patients with r/r follicular lymphoma
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
1:01
latest advances in myelofibrosis treatment
-
2:04
autologous transplantation followed by maintenance vs maintenance alone in patients with mcl